PMHNP
Helper
Practice Questions
Case Library
Clinical Library
Medications
Diagnoses
Differentials
Study Tools
Flashcards
Study Plan
Pricing
About
Practice Questions
Case Library
Medications
Diagnoses
Differentials
Flashcards
Study Plan
Pricing
About
Questions
/
Ethics & Legal
/
Q82 of 149
intermediate
telehealth
controlled-substances
DEA-regulations
prescribing
AANPCB
A PMHNP is prescribing a controlled substance to a patient during a telehealth visit. What additional considerations apply compared to an in-person visit?
A
Controlled substances cannot be prescribed via telehealth under any circumstances.
B
The PMHNP should verify applicable DEA, state, and federal regulations regarding telehealth prescribing of controlled substances, which have evolved significantly. Considerations include whether an initial in-person evaluation is required, proper patient identification, state-specific telehealth prescribing limitations, and PDMP checks.
C
Telehealth prescribing of controlled substances follows identical rules as in-person prescribing.
D
Only Schedule IV and V medications can be prescribed via telehealth.
← Previous
All Ethics & Legal
Next →